Linda M Rubinstein is CHIEF FINANCIAL OFFICER of Adverum Biotechnologies, Inc.. Currently has a direct ownership of 0 shares of ADVM, which is worth approximately $0. The most recent transaction as insider was on Dec 09, 2025, when has been sold 8,125 shares (Common Stock - Restricted Stock Units) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Linda M Rubinstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
8,125 Reduced 100.0%
0 Common Stock - Restric...
Dec 09 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
61,150 Reduced 100.0%
0 Common Stock
Dec 09 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
42,000 Reduced 100.0%
0 Common Stock - Perform...
Dec 09 2025
BUY
Exercise of conversion of derivative security
$204,750 $4.2 p/Share
48,750 Added 44.36%
61,150 Common Stock
Dec 09 2025
BUY
Grant, award, or other acquisition
-
42,000 Added 50.0%
42,000 Common Stock - Perform...
Feb 25 2025
BUY
Grant, award, or other acquisition
-
8,125 Added 29.6%
19,325 Common Stock
Jun 07 2023
BUY
Open market or private purchase
$145,000 $1.45 p/Share
100,000 Added 50.0%
100,000 Common Stock

Also insider at

BIOC
BIOCEPT INC Healthcare
LMR

Linda M Rubinstein

CHIEF FINANCIAL OFFICER
San Diego, CA

Track Institutional and Insider Activities on ADVM

Follow Adverum Biotechnologies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADVM shares.

Notify only if

Insider Trading

Get notified when an Adverum Biotechnologies, Inc. insider buys or sells ADVM shares.

Notify only if

News

Receive news related to Adverum Biotechnologies, Inc.

Track Activities on ADVM